The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Combination pharmacotherapy for management of chronic pain: from bench to bedside
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Central sensitization: implications for the diagnosis and treatment of pain
Woolf, C. J. (2011) · Pain · doi:10.1016/j.pain.2010.09.030 · Cited by 4,771
Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage
Costigan, M., Scholz, J., & Woolf, C. J. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135531 · Cited by 2,025
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Self-citationThe Cerebral Signature for Pain Perception and Its Modulation
Tracey, I., & Mantyh, P. W. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.012 · Cited by 1,843
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Mechanisms of neuropathic pain
Campbell, J. N., & Meyer, R. A. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.021 · Cited by 1,471
Law, M. R., Wald, N. J., Morris, J. K., & Jordan, R. E. (2003) · BMJ · doi:10.1136/bmj.326.7404.1427 · Cited by 1,232
Small fibre pathology in patients with fibromyalgia syndrome
Üçeyler, N., Zeller, D., Kahn, A.-K., Kewenig, S., Kittel-Schneider, S., Schmid, A., Casanova-Molla, J., Reiners, K., & Sommer, C. (2013) · Brain · doi:10.1093/brain/awt053 · Cited by 498
Guidelines on the management of fibromyalgia syndrome – A systematic review
Häuser, W., Thieme, K., & Turk, D. C. (2010) · European Journal of Pain · doi:10.1016/j.ejpain.2009.01.006 · Cited by 347
Research works printed but not linked: 74
- Gaskin, 2012, The economic costs of pain in the United States, J Pain, 13, 715, 10.1016/j.jpain.2012.03.009 · DOI · Paper page
- Sikandar, 2013, No need for translation when the same language is spoken, Br J Anaesth, 111, 3, 10.1093/bja/aet210 · DOI
- Chaparro, 2012, Combination pharmacotherapy for the treatment of neuropathic pain in adults, Cochrane Database Syst Rev, 7
- Gilron, 2005, Combination pharmacotherapy for neuropathic pain: current evidence and future directions, Expert Rev Neurother, 5, 823, 10.1586/14737175.5.6.823 · DOI
- Juniper, 2002, Impact of inhaled salmeterol/fluticasone propionate combination product versus budesonide on the health-related quality of life of patients with asthma, Am J Respir Med, 1, 435, 10.1007/BF03257170 · DOI
- Lilenbaum, 1998, Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival, Cancer, 82, 116, 10.1002/(SICI)1097-0142(19980101)82:1<116::AID-CNCR14>3.0.CO;2-5 · doi:10.1002/(sici)1097-0142(19980101)82:1<116::aid-cncr14>3.0.co;2-5
- Berger, 2012, Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study, BMC Neurol, 12, 8, 10.1186/1471-2377-12-8 · DOI
- Finnerup, 2010, The evidence for pharmacological treatment of neuropathic pain, Pain, 150, 573, 10.1016/j.pain.2010.06.019 · DOI · Paper page
- Basbaum, 2009, Cellular and molecular mechanisms of pain, Cell, 139, 267, 10.1016/j.cell.2009.09.028 · DOI · Paper page
- Tallarida, 1992, Statistical analysis of drug combinations for synergism, Pain, 49, 93, 10.1016/0304-3959(92)90193-F · DOI · Paper page
- Dickenson, 1993, Combination therapy in analgesia; seeking synergy, Curr Opin Anaesthesiol, 6, 861, 10.1097/00001503-199310000-00020 · doi:10.1097/00001503-199310000-00020
- Straube, 2011, Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics?, BMC Neurol, 11, 43, 10.1186/1471-2377-11-43 · DOI
- Saab, 2008, Alarm or curse? The pain of neuroinflammation, Brain Res Rev, 58, 226, 10.1016/j.brainresrev.2008.04.002 · DOI
- Schweinhardt, 2010, Pain imaging in health and disease: how far have we come, J Clin Invest, 120, 3788, 10.1172/JCI43498 · DOI · Paper page
- Jensen, 2003, Translation of symptoms and signs into mechanisms in neuropathic pain, Pain, 102, 1, 10.1016/s0304-3959(03)00006-x · DOI · Paper page
- Jänig, 1996, Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma, Prog Brain Res, 113, 161, 10.1016/S0079-6123(08)61087-0 · DOI · Paper page
- Jensen, 2011, A new definition of neuropathic pain, Pain, 152, 2204, 10.1016/j.pain.2011.06.017 · DOI · Paper page
- Maier, 2010, Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes, Pain, 150, 439, 10.1016/j.pain.2010.05.002 · DOI · Paper page
- Graven-Nielsen, 2010, Assessment of mechanisms in localized and widespread musculoskeletal pain, Nat Rev Rheumatol, 6, 599, 10.1038/nrrheum.2010.107 · DOI · Paper page
- Leavitt, 1986, Characteristics and frequency of malingering among patients with low back pain, Pain, 25, 357, 10.1016/0304-3959(86)90239-3 · doi:10.1016/0304-3959(86)90239-3
- De Felice, 2011, Engagement of descending inhibition from the rostral ventromedial medulla protects against chronic neuropathic pain, Pain, 152, 2701, 10.1016/j.pain.2011.06.008 · DOI · Paper page
- Porreca, 2001, Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor, J Neurosci, 21, 5281, 10.1523/JNEUROSCI.21-14-05281.2001 · DOI · Paper page
- Suzuki, 2004, Bad news from the brain: descending 5-HT pathways that control spinal pain processing, Trends Pharmacol Sci, 25, 613, 10.1016/j.tips.2004.10.002 · DOI · Paper page
- Bennett, 2007, Using screening tools to identify neuropathic pain, Pain, 127, 199, 10.1016/j.pain.2006.10.034 · DOI · Paper page
- Turk, 2010, Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain, Mayo Clin Proc, 85, S42, 10.4065/mcp.2009.0648 · DOI · Paper page
- Hochberg, 2012, American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee, Arthritis Care Res (Hoboken), 64, 465, 10.1002/acr.21596 · DOI · Paper page
- Koes, 2010, An updated overview of clinical guidelines for the management of non-specific low back pain in primary care, Eur Spine J, 19, 2075, 10.1007/s00586-010-1502-y · DOI · Paper page
- Finnerup, 2006, Mechanisms of disease: mechanism-based classification of neuropathic pain—a critical analysis, Nat Clin Pract Neurol, 2, 107, 10.1038/ncpneuro0118 · DOI
- Hanna, 2008, Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients, Eur J Pain, 12, 804, 10.1016/j.ejpain.2007.12.010 · DOI · Paper page
- Khoromi, 2007, Morphine, nortriptyline and their combination vs placebo in patients with chronic lumbar root pain, Pain, 130, 66, 10.1016/j.pain.2006.10.029 · DOI · Paper page
- Eichenberger, 2008, Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds, Anesth Analg, 106, 1265, 10.1213/ane.0b013e3181685014 · DOI · Paper page
- Graff-Radford, 2000, Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia, Clin J Pain, 16, 188, 10.1097/00002508-200009000-00002 · DOI
- Dib-Hajj, 2013, The Na(V)1.7 sodium channel: from molecule to man, Nat Rev Neurosci, 14, 49, 10.1038/nrn3404 · DOI · Paper page
- Faber, 2012, Gain-of-function Nav1.8 mutations in painful neuropathy, Proc Natl Acad Sci USA, 109, 19444, 10.1073/pnas.1216080109 · DOI · Paper page
- Dib-Hajj, 2010, Sodium channels in normal and pathological pain, Annu Rev Neurosci, 33, 325, 10.1146/annurev-neuro-060909-153234 · DOI · Paper page
- Fertleman, 2006, SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes, Neuron, 52, 767, 10.1016/j.neuron.2006.10.006 · DOI · Paper page
- Bauer, 2009, The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin, J Neurosci, 29, 4076, 10.1523/JNEUROSCI.0356-09.2009 · DOI · Paper page
- D'Mello, 2008, Spinal cord mechanisms of pain, Br J Anaesth, 101, 8, 10.1093/bja/aen088 · DOI · Paper page
- Bannister, 2009, Preclinical and early clinical investigations related to monoaminergic pain modulation, Neurotherapeutics, 6, 703, 10.1016/j.nurt.2009.07.009 · DOI · Paper page
- Ossipov, 2010, Central modulation of pain, J Clin Invest, 120, 3779, 10.1172/JCI43766 · DOI · Paper page
- Bee, 2008, Descending facilitation from the brainstem determines behavioural and neuronal hypersensitivity following nerve injury and efficacy of pregabalin, Pain, 140, 209, 10.1016/j.pain.2008.08.008 · DOI
- Yamamoto, 1992, Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy, Neurosci Lett, 135, 67, 10.1016/0304-3940(92)90137-V · DOI
- Gilron, 2003, Gabapentin blocks and reverses antinociceptive morphine tolerance in the rat paw-pressure and tail-flick tests, Anesthesiology, 98, 1288, 10.1097/00000542-200305000-00037 · DOI
- Matthews, 2002, A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy, Anesthesiology, 96, 633, 10.1097/00000542-200203000-00020 · doi:10.1097/00000542-200203000-00020
- Christoph, 2011, Synergistic antihypersensitive effects of pregabalin and tapentadol in a rat model of neuropathic pain, Eur J Pharmacol, 666, 72, 10.1016/j.ejphar.2011.05.029 · doi:10.1016/j.ejphar.2011.05.029
- Virani, 1997, Drug interactions in human neuropathic pain pharmacotherapy, Pain, 73, 3, 10.1016/S0304-3959(97)00041-9 · DOI
- Haanpää, 2010, Treatment considerations for patients with neuropathic pain and other medical comorbidities, Mayo Clin Proc, 85, S15, 10.4065/mcp.2009.0645 · DOI
- Elia, 2005, Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials, Anesthesiology, 103, 1296, 10.1097/00000542-200512000-00025 · DOI · Paper page
- Gilron, 2005, Morphine, gabapentin, or their combination for neuropathic pain, N Engl J Med, 352, 1324, 10.1056/NEJMoa042580 · DOI · Paper page
- Gilron, 2009, Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial, Lancet, 374, 1252, 10.1016/S0140-6736(09)61081-3 · DOI · Paper page
- Gore, 2012, The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings, Spine (Phila Pa 1976), 37, E668, 10.1097/BRS.0b013e318241e5de · DOI · Paper page
- Gore, 2011, Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis, J Med Econ, 14, 497, 10.3111/13696998.2011.594347 · DOI
- Agrawal, 2009, Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study, Diabetes Res Clin Pract, 83, 371, 10.1016/j.diabres.2008.12.018 · DOI
- Amr, 2010, Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial, Pain Physician, 13, 245, 10.36076/ppj.2010/13/245 · DOI
- Caraceni, 2004, Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group, J Clin Oncol, 22, 2909, 10.1200/JCO.2004.08.141 · DOI · Paper page
- Freeman, 2007, Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy, Curr Med Res Opin, 23, 147, 10.1185/030079906X162674 · DOI
- Gomez-Perez, 1985, Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy: a double-blind cross-over study, Pain, 23, 395, 10.1016/0304-3959(85)90010-7 · DOI · Paper page
- Gomez-Perez, 1996, Nortriptyline-fluphenazine vs carbamazepine in the symptomatic treatment of diabetic neuropathy, Arch Med Res, 27, 525
- Lynch, 2003, A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain, Clin J Pain, 19, 323, 10.1097/00002508-200309000-00007 · DOI
- Lynch, 2005, Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial, Anesthesiology, 103, 140, 10.1097/00000542-200507000-00021 · DOI
- McCleane, 2000, Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study, Br J Clin Pharmacol, 49, 574, 10.1046/j.1365-2125.2000.00200.x · DOI · Paper page
- McCleane, 2003, A randomised, double blind, placebo controlled crossover study of the cholecystokinin 2 antagonist L-365,260 as an adjunct to strong opioids in chronic human neuropathic pain, Neurosci Lett, 338, 151, 10.1016/S0304-3940(02)01388-5 · DOI
- Mercadante, 2002, Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study, Tumori, 88, 239, 10.1177/030089160208800310 · DOI · Paper page
- Tonet, 2008, Evaluation of oral ketamine for the treatment of neuropathic pain, Rev Bras Med, 65, 214
- Zin, 2010, A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin, J Pain, 11, 462, 10.1016/j.jpain.2009.09.003 · DOI
- Ramiro, 2011, Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis), Cochrane Database Syst Rev, 10
- Buescher, 2004, Does acetaminophen and NSAID combined relieve osteoarthritis pain better than either alone?, J Fam Pract, 53, 501
- Romanò, 2012, Antineuropathic and antinociceptive drugs combination in patients with chronic low back pain: a systematic review, Pain Res Treat, 2012, 154781
- Romanò, 2009, Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain, J Orthop Traumatol, 10, 185, 10.1007/s10195-009-0077-z · DOI
- Fallon, 2011, A systematic review of combination step III opioid therapy in cancer pain: an EPCRC opioid guideline project, Palliat Med, 25, 597, 10.1177/0269216310392101 · doi:10.1177/0269216310392101
- Lauretti, 2003, Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients, Br J Cancer, 89, 2027, 10.1038/sj.bjc.6601365 · DOI
- Raja, 2005, Combination therapy for neuropathic pain: which drugs, which combination, which patients?, N Engl J Med, 352, 1373, 10.1056/NEJMe058039 · DOI
- Jyrkkä, 2009, Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study—a cross-sectional analysis, Drugs Aging, 26, 493, 10.2165/00002512-200926060-00006 · DOI · Paper page
- Podolsky, 2011, Combination drugs: hype, harm, and hope, N Engl J Med, 365, 488, 10.1056/NEJMp1106161 · DOI
Cited by
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Self-citationAllodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms
Jensen, T. S., & Finnerup, N. B. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70102-4 · Cited by 976
Self-citationNeuropathic Pain: Principles of Diagnosis and Treatment
Gilron, I., Baron, R., & Jensen, T. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.01.018 · Cited by 540
Self-citationMoulin, D., Boulanger, A., Clark, A., Clarke, H., Dao, T., Finley, G., Furlan, A., Gilron, I., Gordon, A., Morley-Forster, P., et al. (2014) · Pain Research and Management · doi:10.1155/2014/754693 · Cited by 529
Self-citationDemant, D. T., Lund, K., Vollert, J., Maier, C., Segerdahl, M., Finnerup, N. B., Jensen, T. S., & Sindrup, S. H. (2014) · Pain · doi:10.1016/j.pain.2014.08.014 · Cited by 440
Self-citation
Metadata
- Authors
- Gilron, I., Jensen, T. S., & Dickenson, A. H.
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 12
- Issue
- 11
- Pages
- 1084-1095
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2171872873
- Cited by
- 240
- References
- 11
- FWCI
- 15.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Canadian Institutes of Health Research (MSH-55041)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combination pharmacotherapy for management of chronic pain: from bench to bedside. https://app.cochat.ai/papers/10.1016/s1474-4422(13)70193-5
- The paper
- Gilron, I., Jensen, T. S., & Dickenson, A. H. (2013). Combination pharmacotherapy for management of chronic pain: from bench to bedside. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(13)70193-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.